Anti-VEGF Drug Trial Results in AMD Released Early (CME/CE)
(MedPage Today) -- Full publication of results from the head-to-head study of bevacizumab (Avastin) and ranibizumab (Lucentis) in "wet" age-related macular degeneration has confirmed information previously leaked to the media -- that the two drugs differed little in preserving visual acuity.